Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

7 Companies Set To Capitalize On Recreational Canadian Cannabis

Mar 27, 2017 • 4:15 PM EDT
THE NEW YOU (4).png
4 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

The cannabis sector continues to be the fastest growing industry in the world and it continues to provide investors will ample opportunities.  Although Canada has been one of the hottest places to invest over the last year, Canadian cannabis stocks have been under pressure over the last two months.

Yesterday, CBC News reported that the Canadian government will announce legislation next month to legalize recreational cannabis by July 1, 2018. CBC said it learned that the legislation will be announced the week of April 10th and will broadly follow the recommendation of a federally appointed task force chaired by former liberal Justice Minister Anne McLellan. Per the CBC, Parliamentary Secretary to the Minister of Justice Bill Blair briefed the Liberal caucus on the roll-out plan and the legislation over the weekend.

Cannabis stocks will rally off this news and we want to highlight seven important company developments to hit the newswire today.

  1. Invictus MD (IMH: CSE) (IVITF: OTC) has received conditional approval to list its common shares for trading on the TSX Venture Exchange. This development follows several significant company developments and we think this is a stock to watch.
  2. Canabo Medical (CMM.V: TSX Venture) (CAMDF: OTCQB) announced that it opened its 14th Cannabinoid Medical Clinic (or CMClinics) in St. Catharine’s, Ontario. Canabo plans to open 8 additional clinics in 2017. Since beginning operations in 2014, the company now has clinic locations in Toronto, Barrie, St. Catharine’s, Burlington, Stoney Creek, Ottawa, Hamilton, Halifax, St. John’s, Moncton, Kingston, Edmonton, Calgary and Chilliwack.
  3. Insys Therapeutics, Inc. (INSY) found a new President and CEO and reported that Saeed Motahari assume the role, effective April 17th. Prior to joining Insys, Motahari was Purdue Pharma’s Chief Commercial Officer and played a key role in the transformation of the company’s commercial organization and contributed to the business development strategy.
  4. Zynerba Pharmaceuticals (ZYNE) reported fourth quarter and full-year financial results for the period that ended on December 31st and provided an overview of recent operational highlights.
  5. Golden Leaf Holdings Ltd. (GLDFF) signed a binding agreement to acquire a cultivation and extraction license in Nevada from NevWa (doing business as Grassroots). NevWa’s cultivation and extraction license, based out of Sparks, Nevada, allows for the distribution and sale of products across the state.
  6. MassRoots, Inc. (MSRT) announced that it launched a new website that enables the company to broaden its audience and more effectively monetize users and web-traffic.
  7. Aphria Inc. (APH.V) (APHQF) made an additional investment of $3 million in Copperstate Farms Investors. The investment will advance its capital expenditure program related to extractions, lighting and power generation. This increases Aphria’s membership units from 10% to 18.5%. Investors owns a 95% interest in Copperstate Farms. The remaining 5% interest in Copperstate is owned through its Aphria’s subsidiary 


Important Investor Disclosures 

Disclosure.  Compensated Affiliate.  This report was authored by and is property of Mushroomstocks.  All information and data relied upon in drafting this report is publicly available.  The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report.  Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice.  Any projections or other information generated by Mushroomstocks regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results.  None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment.  This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation.  The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals.  It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction.  Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks.  The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission.  Please contact a Financial Advisor for professional advice regarding any and all securities investments.  This report is intended for informational purposes only.  Mushroomstocks’s officers, directors, employees, affiliates, or subsidiaries may have positions in securities covered by Mushroomstocks.  Mushroomstocks receives compensation from the company and/or has a position in the securities mentioned in this report

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.